AF Clinical Trials in Ann Arbor, Michigan

19 recruitingAnn Arbor, Michigan

Showing 119 of 19 trials

Recruiting
Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled6 locationsNCT05922761
Recruiting
Phase 3

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled175 locationsNCT01804686
Recruiting
Not Applicable

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

Atrial Fibrillation (AF)Persistant Atrial FibrillationParoxysmal AF
Arga Medtech SA360 enrolled27 locationsNCT06784466
Recruiting
Phase 3

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Chronic Graft Versus Host Disease
Incyte Corporation240 enrolled122 locationsNCT06585774
Recruiting
Phase 2

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

Chronic Graft Versus Host Disease
Syndax Pharmaceuticals296 enrolled121 locationsNCT04710576
Recruiting
Phase 4

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Acute Kidney Injury (AKI)AnesthesiaMyocardial Injury After Noncardiac Surgery (MINS)+4 more
University of California, San Francisco18,000 enrolled10 locationsNCT06802224
Recruiting
Phase 3

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Graft-Versus-Host-Disease (GVHD)
Incyte Corporation572 enrolled30 locationsNCT06615050
Recruiting
Phase 2

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Graft vs Host Disease
Boston Children's Hospital160 enrolled15 locationsNCT04380740
Recruiting
Phase 3

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Kidney TransplantDelayed Graft FunctionDGF
Alexion Pharmaceuticals, Inc.450 enrolled130 locationsNCT06830798
Recruiting
Phase 1Phase 2

Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation

Post-operative Atrial Fibrillation (POAF)
University of Michigan70 enrolled1 locationNCT05991700
Recruiting
Not Applicable

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Heart DiseasesCoronary Artery DiseaseCoronary Artery Bypass Grafting
Weill Medical College of Cornell University2,300 enrolled146 locationsNCT04124120
Recruiting
Phase 2

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

deaf-blindRetinitis pigmentosa (RP)Retinal Disease+4 more
Laboratoires Thea81 enrolled27 locationsNCT06627179
Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

Cardiac FailureGraft Rejection
Inova Health Care Services150 enrolled7 locationsNCT06532890
Recruiting
Not Applicable

Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

Acute Kidney InjuryRenal ImpairmentRenal impairment after cardiac surgery.
3ive Labs124 enrolled7 locationsNCT07017933
Recruiting
Phase 1

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

primary graft failure
University of Oklahoma56 enrolled4 locationsNCT03541889
Recruiting
Phase 3

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Low-grade GliomaRapidly Accelerated Fibrosarcoma (RAF) Altered GliomaPediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc.400 enrolled138 locationsNCT05566795
Recruiting
Not Applicable

CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

Atrial FibrillationAblationMaze Procedure+1 more
Pulse Biosciences, Inc.135 enrolled2 locationsNCT06959121
Recruiting
Phase 3

CAR-T Long Term Follow Up (LTFU) Study

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals1,400 enrolled118 locationsNCT02445222
Recruiting

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Chronic Lung DiseaseGraft-Versus-Host DiseaseHematopoietic Cell Transplantation
University of Michigan Rogel Cancer Center375 enrolled6 locationsNCT05866302